Myogen (MYOG) Inactive 10-Q2005 Q1 Quarterly report

Filed: 10 May 05, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Good

New words: abuse, accident, accidental, accomplished, acquisition, adequacy, adhere, afford, AG, agent, aggregate, aimed, alleviate, andForm, appointed, approach, asserting, assume, attract, attractive, avoid, Belgium, belong, beneficiary, bill, blank, blocker, blood, born, Boston, call, called, cancer, cardiac, care, Center, cGMP, Chairman, charter, check, child, choose, CIBC, civil, Colorado, compliant, consent, contamination, create, criminal, curtail, debate, debt, deducting, defect, demand, depriving, detract, diligence, disagree, discourage, discouraging, disrupt, disrupted, documentation, Dr, durable, economic, Eli, eliminate, eliminating, elimination, EMEA, employed, employment, EMPOWER, enacted, encounter, enhanced, ensure, entirety, entrenchment, environmental, epoprostenol, eventual, eventually, exceeding, expansion, exploit, export, fact, factor, false, FAS, FASB, fetal, fit, fluctuate, France, fraud, Freytag, GAAP, Germany, Good, governmental, guidance, guide, handling, health, healthcare, hire, hold, House, hypertrophy, immigration, imposition, improve, improvement, improving, inability, Incentive, incidence, incorporation, infertility, inflation, injury, inspection, instability, interact, Ireland, Italy, kidney, Kingdom, lab, label, labeling, labor, lack, launch, Lazard, lengthy, lesser, LFT, licensor, Lilly, liver, LLC, local, lose, low, Luxembourg, mark, measure, medical, medically, Medicare, medication, Medicinal, merit, milligram, modified, monetary, Morgan, motivate, notice, onForm, orphan, oversight, ownership, passed, pathological, pendency, percent, pertaining, political, pollution, practicing, practitioner, pregnancy, pregnant, pressure, prevailing, printing, promotion, Protracted, radioactive, rare, read, realize, reclassify, recommended, recovery, reform, refused, refusing, regularly, reimportation, remedial, remediation, removal, reputation, requested, reserve, reserved, restate, retain, retention, retrospective, reveal, revise, revised, revision, Roche, royalty, Secretary, seizure, shorten, shorter, smaller, source, Southwestern, specialty, sponsored, standard, statute, stockholder, storage, store, strain, strategy, strict, subset, suffer, suffering, Suisse, superior, supply, tadalafil, team, terrorism, testicular, tissue, tool, toxic, toxicity, track, train, transition, transmit, travel, treasury, treprostinil, tritium, turn, ultimate, unforeseen, University, unmet, unsuccessful, unvested, utilizing, vi, view, vii, violation, war, waste, widespread, William, withdrawn, women, World, worldwide

Removed: accretion, accrue, accrued, achieved, analytical, August, communicated, concurrent, continually, conversion, converted, demonstrating, designed, disclosed, discount, Flolan, half, initiating, inotrope, jeopardized, mandatorily, occurring, positive, processed, ratio, reach, redeemable, reimbursing, Remodulin, SAB, secondary, slightly, stemming, structure, therapy, Tracleer, underwriter, Viagra, wean

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

MYOG similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION

Pursuant to Section 906 of the Public Company Accounting Reform and Investor Protection Act of 2002 (18 U.S.C. § 1350, as adopted), J. William Freytag, the Chief Executive Officer of Myogen, Inc. (the “Company”), and Joseph L. Turner, the Chief Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:

1. The Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2005, to which this Certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Periodic Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Periodic Report and results of operations of the Company for the periods covered by the Periodic Report.


Dated: May 10, 2005

/s/ J. William Freytag		/s/ Joseph L. Turner

J. William Freytag		Joseph L. Turner
Chief Executive Officer		Chief Financial Officer
(Principal Executive Officer)		(Principal Financial Officer)

A signed original of this written statement required by Section 906 has been provided to Myogen, Inc. and will be retained by Myogen, Inc. and furnished to the Securities and Exchange Commission (“SEC”) or its staff upon request. This certification “accompanies” the Form 10-Q to which it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.